Abstract
Human exploration of space for extended missions to the Moon, Mars, and other destinations
poses specific challenges for the health of astronauts. Microgravity, cosmic radiation, disrupted
circadian rhythms, fluid shift, muscle atrophy, immune alteration, and psychological stress
affect health (Kast et al., 2017; Patel et al., 2025). Pharmaceuticals play a critical role in treating
conditions in space, such as motion sickness, infection, pain, bone loss, sleep disorders, and
cardiovascular problems. Yet, established drug principles might not function equally in space
due to modifications of drug absorption, distribution, metabolism, and excretion. In addition,
drug stability can be reduced under space environment (Int. J. Pharm, 2025). Experiments on
the International Space Station (ISS) have recognized problems such as degradation of drugs
by radiation, difficulties with repackaging, and extensive storage periods. Several drugs might
be outdated by the time the mission is over (Diaz et al., 2024; Du et al., 2025). Space
pharmacology addresses these issues through research on drug stability, formulation, and
delivery in microgravity and radiation. It also investigates individualized therapies based on
pharmacogenomics (Nelson et al., 2024). New technologies consist of 3D-printed medicines,
improved drug delivery systems, AI-driven models, and tele pharmacy to provide efficient
medication use in deep-space missions (Varda Space Industries, 2025). Radiation-resistant
formulations of drugs, on-demand production of drugs, customized dosing, dispensing systems
using automation, and rigorous regulations to harmonize in-flight use of drugs are what future
endeavours should prioritize. Blending state-of-the-art monitoring technologies, AI, and
pharmacogenomics will enhance the health of astronauts, minimize drug instability, and
provide effective treatment. Continued research in space pharmacology is necessary for the
continued safe presence of humans in space and the success of missions on interplanetary
travel.